Myriad Genetics, Inc.MYGNNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
104.69%
↑ 104% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthAccelerating
Average
-2537.57%
Historical baseline
PeriodValue
2025104.69%
202479.15%
2023-21.50%
2022-25366.67%
2021101.50%
2020-179.41%
2019-32.76%
2018-30.14%
20177.39%
2016-37.94%